Total Payments
$41,835
2024 Payments
$638.21
Companies
33
Transactions
137
Medicare Patients
15,200
Medicare Billing
$7.8M
Payment Breakdown by Category
Other$20,050 (47.9%)
Research$11,171 (26.7%)
Food & Beverage$4,072 (9.7%)
Consulting$3,100 (7.4%)
Travel$3,067 (7.3%)
Education$375.83 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20,050 | 6 | 47.9% |
| Unspecified | $11,171 | 2 | 26.7% |
| Food and Beverage | $4,072 | 100 | 9.7% |
| Consulting Fee | $3,100 | 6 | 7.4% |
| Travel and Lodging | $3,067 | 13 | 7.3% |
| Education | $375.83 | 10 | 0.9% |
Payments by Type
General
$30,665
135 transactions
Research
$11,171
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $20,501 | 47 | $0 (2024) |
| Celgene Corporation | $11,202 | 4 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $6,046 | 13 | $0 (2019) |
| Foundation Medicine, Inc. | $1,355 | 4 | $0 (2019) |
| Astellas Pharma US Inc | $402.18 | 6 | $0 (2023) |
| PFIZER INC. | $334.69 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $210.52 | 10 | $0 (2021) |
| Seattle Genetics, Inc. | $208.84 | 2 | $0 (2019) |
| Sirtex Medical Inc | $188.56 | 2 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $179.09 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $638.21 | 7 | PFIZER INC. ($239.65) |
| 2023 | $273.91 | 6 | Astellas Pharma US Inc ($215.45) |
| 2022 | $654.79 | 19 | E.R. Squibb & Sons, L.L.C. ($423.72) |
| 2021 | $178.63 | 6 | E.R. Squibb & Sons, L.L.C. ($100.00) |
| 2020 | $33.94 | 2 | Janssen Scientific Affairs, LLC ($21.89) |
| 2019 | $9,456 | 41 | Merck Sharp & Dohme Corporation ($5,700) |
| 2018 | $7,301 | 29 | E.R. Squibb & Sons, L.L.C. ($5,055) |
| 2017 | $23,299 | 27 | E.R. Squibb & Sons, L.L.C. ($12,108) |
All Payment Transactions
137 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Oncology | ||||||
| 10/17/2024 | PFIZER INC. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $114.65 | General |
| Category: Oncology | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 09/04/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $38.20 | General |
| 08/15/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 02/20/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $23.52 | General |
| 08/02/2023 | ImmunoGen, Inc. | Elahere (Biological) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Oncology | ||||||
| 06/29/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 06/26/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
| 06/13/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Neuromodulation | ||||||
| 06/09/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Oncology | ||||||
| 02/15/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Oncology | ||||||
| 12/15/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $24.39 | General |
| 12/15/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $8.07 | General |
| 12/15/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $7.06 | General |
| 12/14/2022 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Oncology | ||||||
| 11/30/2022 | Tactile Systems Technology Inc | Flexitouch Plus (Device), entre | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 11/10/2022 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Oncology | ||||||
| 09/20/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $2.11 | General |
| Category: Oncology | ||||||
| 09/14/2022 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Oncology | ||||||
| 08/03/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $5.98 | General |
| Category: Oncology | ||||||
| 07/19/2022 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Oncology | ||||||
| 06/30/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $29.68 | General |
| 06/07/2022 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $110.42 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ABI-007-NSCL-005 | Celgene Corporation | $10,811 | 1 |
| ABI-007-NSCL-005 - Safety and Efficacy of nab-paclitaxel (Abraxane) in Combination with Carboplatin as First Line Treatment in Elderly Subjects with Advance Non-Small Cell Lung Cancer (NSCLC): A Phase IV, Randomized, Op | Celgene Corporation | $360.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 71 | 3,557 | 205,722 | $6.7M | $1.2M |
| 2022 | 73 | 3,689 | 220,846 | $7.9M | $1.6M |
| 2021 | 79 | 4,375 | 347,553 | $12.8M | $2.7M |
| 2020 | 65 | 3,579 | 276,360 | $10.1M | $2.3M |
Total Patients
15,200
Total Services
1,050,481
Medicare Billing
$7.8M
Procedure Codes
288
All Medicare Procedures & Services
288 procedure records from CMS Medicare Utilization — Page 12 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96361 | Hydration infusion into a vein | Office | 2020 | 24 | 45 | $3,375 | $474.03 | 14.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 118 | 4,348 | $4,348 | $421.48 | 9.7% |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | Office | 2020 | 60 | 1,750 | $42,000 | $380.15 | 0.9% |
| J3475 | Injection, magnesium sulfate, per 500 mg | Office | 2020 | 38 | 674 | $4,044 | $279.50 | 6.9% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2020 | 13 | 14 | $1,596 | $278.30 | 17.4% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2020 | 64 | 129 | $2,451 | $256.81 | 10.5% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2020 | 94 | 324 | $1,374 | $192.09 | 14.0% |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | Office | 2020 | 11 | 12 | $322.00 | $134.71 | 41.8% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 11 | 16 | $544.00 | $103.00 | 18.9% |
| J3490 | Unclassified drugs | Office | 2020 | 46 | 144 | $1,168 | $93.22 | 8.0% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2020 | 11 | 16 | $352.00 | $60.48 | 17.2% |
| J3480 | Injection, potassium chloride, per 2 meq | Office | 2020 | 22 | 325 | $325.00 | $40.81 | 12.6% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2020 | 22 | 28 | $532.00 | $27.62 | 5.2% |
About Dr. Leonardo Forero, MD
Dr. Leonardo Forero, MD is a Hematology & Oncology healthcare provider based in Amarillo, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700847464.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonardo Forero, MD has received a total of $41,835 in payments from pharmaceutical and medical device companies, with $638.21 received in 2024. These payments were reported across 137 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($20,050).
As a Medicare-enrolled provider, Forero has provided services to 15,200 Medicare beneficiaries, totaling 1,050,481 services with total Medicare billing of $7.8M. Data is available for 4 years (2020–2023), covering 288 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Medical Oncology
- Location Amarillo, TX
- Active Since 03/31/2006
- Last Updated 12/20/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1700847464
Products in Payments
- OPDIVO (Biological) $19,821
- Abraxane (Drug) $11,171
- KEYTRUDA (Biological) $6,046
- FOUNDATIONACT (Device) $1,329
- ADCETRIS (Biological) $323.49
- SIR-Spheres Microspheres (Device) $188.56
- PADCEV (Biological) $125.00
- ERLEADA (Drug) $121.84
- XTANDI (Drug) $115.64
- TUKYSA (Drug) $110.42
- KISQALI (Drug) $102.72
- Enhertu (Drug) $90.00
- Erleada (Drug) $80.49
- DARZALEX (Drug) $76.71
- Oncology (Device) $76.01
- Stivarga (Drug) $73.28
- VERZENIO (Drug) $72.19
- PROCLAIM (Device) $47.53
- LIBTAYO (Drug) $44.68
- MEKINIST (Drug) $44.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Amarillo
Dr. Andrew Mak, M.d, M.D
Hematology & Oncology — Payments: $4,481
Hematology & Oncology $4,481
Paul Zorsky, M.d, M.D
Hematology & Oncology — Payments: $2,440
Hematology & Oncology $2,440
Javed Shinwari, M.d, M.D
Hematology & Oncology — Payments: $2,382
Hematology & Oncology $2,382
Dr. Shrestha Patel, D.o, D.O
Hematology & Oncology — Payments: $1,409
Hematology & Oncology $1,409
Dr. Milan Patel, Md, MD
Hematology & Oncology — Payments: $1,233
Hematology & Oncology $1,233
Dr. William Esler, Md, MD
Hematology & Oncology — Payments: $43.59
Hematology & Oncology $43.59